Furosemide in Early Acute Kidney Injury (SPARK)

Clinical Trial: Furosemide in Early Acute Kidney Injury (SPARK)

Sponsor and Collaborators
University of Alberta

Contact
Sean M Bagshaw, MD MSc
(780)-407-6755
bagshaw@ualberta.ca

Principal Investigator
Sean M Bagshaw, MD MSc
University of Alberta

ClinicalTrials.gov Identifier
NCT00978354

More in Acute Kidney Injury Clinical Trials

Accuracy of Pre-existing Risk Scoring Models for Predicting Acute Kidney Injury in ...

A look at the following clinical trial: Accuracy of Pre-existing Risk Scoring Models for Predicting Acute Kidney Injury in Patients Who Underwent Aortic Surgery Using a Gray Zone Approach.

Effect of Sodium Bicarbonate on Prevention of Acute Kidney Injury in High ...

A look at the following clinical trial: Effect of Sodium Bicarbonate on Prevention of Acute Kidney Injury in High Risk Patients Undergoing Off-pump Coronary Artery Bypass (OPCAB).

A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery ...

A look at the following clinical trial: A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI).